125 related articles for article (PubMed ID: 1328013)
21. Smooth muscle-derived nitric oxide is elevated in isolated forearm veins in human alcoholic cirrhosis.
Ryan J; Jennings G; Dudley F; Chin-Dusting J
Clin Sci (Lond); 1996 Jul; 91(1):23-8. PubMed ID: 8774256
[TBL] [Abstract][Full Text] [Related]
22. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis.
Mizumoto M; Arii S; Furutani M; Nakamura T; Ishigami S; Monden K; Ishiguro S; Fujita S; Imamura M
J Surg Res; 1997 Jul; 70(2):124-33. PubMed ID: 9245560
[TBL] [Abstract][Full Text] [Related]
23. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats.
Van de Casteele M; Hösli M; Sägesser H; Reichen J
J Hepatol; 1999 Aug; 31(2):300-5. PubMed ID: 10453944
[TBL] [Abstract][Full Text] [Related]
24. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
[TBL] [Abstract][Full Text] [Related]
25. Effects of endothelin-1 and inhibition of nitric oxide production with NG-monomethyl-L-arginine on arterial pressure and regional blood flow in anesthetized rats.
Takahashi H; Nakanishi T; Nishimura M; Tanaka H; Yoshimura M
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S176-8. PubMed ID: 1282961
[TBL] [Abstract][Full Text] [Related]
26. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats.
Sieber CC; Lopez-Talavera JC; Groszmann RJ
Gastroenterology; 1993 Jun; 104(6):1750-4. PubMed ID: 8388839
[TBL] [Abstract][Full Text] [Related]
27. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
[TBL] [Abstract][Full Text] [Related]
28. N omega-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats.
Lee FY; Colombato LA; Albillos A; Groszmann RJ
Hepatology; 1993 Jan; 17(1):84-90. PubMed ID: 8423045
[TBL] [Abstract][Full Text] [Related]
29. Cerebral blood flow and cerebrovascular reactivity after inhibition of nitric oxide synthesis in conscious goats.
Fernández N; García JL; García-Villalón AL; Monge L; Gómez B; Diéguez G
Br J Pharmacol; 1993 Sep; 110(1):428-34. PubMed ID: 8220904
[TBL] [Abstract][Full Text] [Related]
30. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide influences blood flow distribution in renovascular hypertension.
Sigmon DH; Beierwaltes WH
Hypertension; 1994 Jan; 23(1 Suppl):I34-9. PubMed ID: 8282373
[TBL] [Abstract][Full Text] [Related]
32. Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat livers.
Loureiro-Silva MR; Iwakiri Y; Abraldes JG; Haq O; Groszmann RJ
J Hepatol; 2006 May; 44(5):886-93. PubMed ID: 16545481
[TBL] [Abstract][Full Text] [Related]
33. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.
Panza JA; García CE; Kilcoyne CM; Quyyumi AA; Cannon RO
Circulation; 1995 Mar; 91(6):1732-8. PubMed ID: 7882481
[TBL] [Abstract][Full Text] [Related]
34. Endogenous nitric oxide attenuates ethanol-induced perturbation of hepatic circulation in the isolated perfused rat liver.
Oshita M; Takei Y; Kawano S; Hijioka T; Masuda E; Goto M; Nishimura Y; Nagai H; Iio S; Tsuji S
Hepatology; 1994 Oct; 20(4 Pt 1):961-5. PubMed ID: 7927238
[TBL] [Abstract][Full Text] [Related]
35. Vasodilatation by endothelium-derived nitric oxide as a major determinant of noradrenaline release.
Halbrügge T; Lütsch K; Thyen A; Graefe KH
J Neural Transm Suppl; 1991; 34():113-9. PubMed ID: 1817156
[TBL] [Abstract][Full Text] [Related]
36. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide.
Castro A; Jiménez W; Clària J; Ros J; Martínez JM; Bosch M; Arroyo V; Piulats J; Rivera F; Rodés J
Hepatology; 1993 Aug; 18(2):367-72. PubMed ID: 8340065
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide does not contribute to sodium retention and peripheral vasodilation induced by partial portal vein ligation in rats.
Murakami S; Bernardo JF; Jacob TD; Branch RA; Sabra R
Ren Physiol Biochem; 1995; 18(4):198-208. PubMed ID: 7481071
[TBL] [Abstract][Full Text] [Related]
38. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans.
Blitzer ML; Loh E; Roddy MA; Stamler JS; Creager MA
J Am Coll Cardiol; 1996 Sep; 28(3):591-6. PubMed ID: 8772744
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
[TBL] [Abstract][Full Text] [Related]
40. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
Calver A; Collier J; Moncada S; Vallance P
J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
